Amphastar Pharmaceuticals, Inc.
AMPH
$19.54
$0.542.84%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -4.55% | 9.99% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.55% | 9.99% | |||
| Cost of Revenue | 4.55% | 5.99% | |||
| Gross Profit | -13.15% | 14.05% | |||
| SG&A Expenses | -4.03% | 15.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.84% | 8.46% | |||
| Operating Income | -26.46% | 14.78% | |||
| Income Before Tax | 48.35% | -45.31% | |||
| Income Tax Expenses | 79.80% | -49.87% | |||
| Earnings from Continuing Operations | 40.80% | -44.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.80% | -44.09% | |||
| EBIT | -26.46% | 14.78% | |||
| EBITDA | -20.15% | 10.12% | |||
| EPS Basic | 42.54% | -43.52% | |||
| Normalized Basic EPS | -27.58% | 14.59% | |||
| EPS Diluted | 37.86% | -42.19% | |||
| Normalized Diluted EPS | -27.68% | 14.49% | |||
| Average Basic Shares Outstanding | -1.22% | -1.01% | |||
| Average Diluted Shares Outstanding | -1.08% | -0.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||